Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

John P. Palmer; Arief A. Suriawinata; Shaofeng Yan; Darcy A. Kerr; Muhammad Z. Afzal; Keisuke Shirai

doi:10.12659/AJCR.938537

18 November 2023 : Case report USA

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Unusual or unexpected effect of treatment

John P. Palmer^1ADEF*, Arief A. Suriawinata^2BDE, Shaofeng Yan^2BDE, Darcy A. Kerr^2BDE, Muhammad Z. Afzal^1ABCE, Keisuke Shirai^1ADEF

DOI: 10.12659/AJCR.938537

Am J Case Rep 2023; 24:e938537

Authors information Article notes Copyright and License information

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 11. Case 4: Patient’s lymph node specimen from left axillary contents shows metastatic melanoma replacing the lymph node; H&E stains, (A) 5×, and (B) 200×. (C) Tumor cells show positive immunostain for MelanA (200×).

Back to the Article

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series

Your Privacy